This report evaluates whether full-text clinical studies and clinical practice guidelines and position statements support the use of transurethral ultrasonic ablation (TULSA) for treatment of localized primary or recurrent prostate cancer.
This report evaluates whether full-text clinical studies and clinical practice guidelines and position statements support the use of transurethral ultrasonic ablation (TULSA) for treatment of localized primary or recurrent prostate cancer.